Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL

Felices, M; Kodal, B; Hinderlie, P; Kaminski, MF; Cooley, S; Weisdorf, DJ; Vallera, DA; Miller, JS; Bachanova, V

Felices, M (reprint author), Univ Minnesota, Div Hematol Oncol & Transplantat, 420 Delaware St SE,Mayo Mail Code 806, Minneapolis, MN 55455 USA.

BLOOD ADVANCES, 2019; 3 (6): 897

Abstract

Chronic lymphocytic leukemia (CLL) is characterized by chronic clonal expansion of mature CD19-expressing B lymphocytes and global dysfunction of immu......

Full Text Link